Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 18, 2020
Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology departmentJonathan de Grégori, Pauline Pistre, Meredith Boutet, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 8, 2018
Phase III randomized trial comparing 5-fluorouracil and oxaliplatin with or without docetaxel in first-line advanced gastric cancer chemotherapy (GASTFOX study)Aziz Zaanan, Emmanuelle Samalin, Thomas Aparicio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 3, 2020
"Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial"Julien Taïeb, Léonor Benhaim, Pierre Laurent Puig, et al.
Obesity Surgery|February 13, 2020
Study of Small Intestinal Bacterial Overgrowth in a Cohort of Patients with Abdominal Symptoms Who Underwent Bariatric SurgeryThomas Mouillot, Nybel Rhyman, Cyril Gauthier, et al.
Medicine|October 27, 2015
Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma: A Multicenter Study by the Association des Gastro-Entérologues OncologuesBertrand Brieau, Céline Lepère, Thomas Walter, et al.
Therapeutic Advances in Medical Oncology|August 7, 2023
Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world settingManon Falette-Puisieux, Jean-Charles Nault, Mohamed Bouattour, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 5, 2023
Atezolizumab plus bevacizumab in advanced hepatocellular carcinoma after treatment failure with multikinase inhibitorsVincent Haghnejad, Marie Muller, Lorraine Blaise, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 20, 2024
Evaluation of serum mid-infrared spectroscopy as new prognostic marker for first-line bevacizumab-based chemotherapy in metastatic colorectal cancerRomain Chautard, Morgane Caulet, Olivier Bouché, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2019
Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Results of a phase I dose-escalation study with panitumumab (FFCD 0904)Véronique Vendrely, Claire Lemanski, Khemara Gnep, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|May 15, 2026
Integrative analysis of circulating biomarkers of colorectal cancer combining mid-infrared spectroscopy and targeted metabolomicsValérie Monbet, William Raoul, Patrick Emond, et al.
Pageof 11